LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions - Tourmaline Bio (NASDAQ: TRML)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TRML Tourmaline Bio
Robinson Ryan F. / officer: Chief Financial Officer
01/27/2025
Buy
$17.00
58,000
$986K
58,000
NASDAQ TRML Tourmaline Bio
MIDDLEKAUFF W BRADFORD / officer: CBO, GC and Secretary
01/27/2025
Buy
$17.00
58,000
$986K
58,000
NASDAQ TRML Tourmaline Bio
Jones Susan Dana / officer: Chief Technology Officer
01/27/2025
Buy
$17.00
58,000
$986K
58,000
NASDAQ TRML Tourmaline Bio
Johnson Kevin Bruce / officer: Chief Regulatory Officer
01/27/2025
Buy
$17.00
58,000
$986K
58,000